MedPath

Fudan University

Fudan University logo
🇨🇳China
Ownership
Private
Established
1905-01-01
Employees
1K
Market Cap
-
Website
http://www.fudan.edu.cn

Clinical Efficacy and sAfety of Intravenous Infusion of Nicorandil During Primary Percutaneous Coronary Intervention

Phase 4
Recruiting
Conditions
ST Elevation Myocardial Infarction
Percutaneous Coronary Intervention
Interventions
Drug: Placebo
Drug: Nicorandil
First Posted Date
2020-12-11
Last Posted Date
2023-09-14
Lead Sponsor
Fudan University
Target Recruit Count
1500
Registration Number
NCT04665648
Locations
🇨🇳

Zhongshan Hospital, Shanghai, Shanghai, China

Effect of Chewing Gum and Mouthwash Before Operation on Sore Throat After General Anesthesia With a Laryngeal Mask

Not Applicable
Conditions
Postoperative Sore Throat
Interventions
Other: Mouthwash
Other: chewed mint gum
First Posted Date
2020-11-25
Last Posted Date
2020-11-25
Lead Sponsor
Fudan University
Target Recruit Count
70
Registration Number
NCT04644900
Locations
🇨🇳

Ethics Committee of The Obstetrics and Gynecology Hospital, Fudan University,, Shanghai, China

The Combination of Immunotherapy and Stereotactic Ablative Radiotherapy in Oligometastatic Gastrointestinal Cancer

Phase 1
Conditions
Oligometastatic Gastrointestinal Cancer
Interventions
Radiation: Stereotactic Ablative Radiotherapy (SABR)
Drug: Camrelizumab for injection (200 mg, iv), D1, Q2W, 14-day cycle
First Posted Date
2020-11-12
Last Posted Date
2020-11-12
Lead Sponsor
Fudan University
Target Recruit Count
21
Registration Number
NCT04625894
Locations
🇨🇳

Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

AG vs mFOLFIRINOX as Neoadjuvant Therapy for Borderline Reseactable and Locally Advanced Pancreatic Cancer

Phase 3
Recruiting
Conditions
Borderline Resectable Pancreatic Cancer
Locally Advanced Pancreatic Adenocarcinoma
Interventions
First Posted Date
2020-11-05
Last Posted Date
2022-01-28
Lead Sponsor
Fudan University
Target Recruit Count
300
Registration Number
NCT04617821
Locations
🇨🇳

Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University, Shanghai, Shanghai, China

Effects of One-handed and Two-handed Mask Ventilation Techniques on Global and Regional Lung Ventilation

Not Applicable
Conditions
Anesthesia
Interventions
Other: Two-handed mask ventilation
Other: One-handed mask ventilation
First Posted Date
2020-11-05
Last Posted Date
2020-11-05
Lead Sponsor
Fudan University
Target Recruit Count
80
Registration Number
NCT04617665

Camrelizumab and Apatinib for Neoadjuvant Therapy in Thyroid Cancer

Phase 2
Conditions
Thyroid Cancer
Interventions
Drug: Camrelizumab and Apatinib
Procedure: surgery
Procedure: core needle biopsy
First Posted Date
2020-11-03
Last Posted Date
2020-11-03
Lead Sponsor
Fudan University
Target Recruit Count
31
Registration Number
NCT04612894
Locations
🇨🇳

Fudan University Shanghai Cancer Center, Shanghai, China

Accuracy of VABB Elite 10G Versus BARD 14G CNB

Phase 3
Conditions
Breast Cancer
Interventions
Device: VABB Elite 10G
Device: BARD 14G CNB
First Posted Date
2020-11-03
Last Posted Date
2021-09-14
Lead Sponsor
Fudan University
Target Recruit Count
1470
Registration Number
NCT04612439
Locations
🇨🇳

Fudan University Shanghai Cancer Center, Shanghai, China

Metformin Plus Megestrol Acetate as a Fertility-sparing Treatment in Patients With Atypical Endometrial Hyperplasia

Phase 2
Terminated
Conditions
Atypical Endometrial Hyperplasia
Interventions
First Posted Date
2020-10-29
Last Posted Date
2022-04-05
Lead Sponsor
Fudan University
Target Recruit Count
12
Registration Number
NCT04607252
Locations
🇨🇳

Obstetrics and Gynecology Hospital, Fudan University, Shanghai, Shanghai, China

Surgical Pleth Index: Predicting the Optimal Timing for Tracheal Intubation During General Anesthesia

Conditions
Trachea Intubation
First Posted Date
2020-10-29
Last Posted Date
2021-12-02
Lead Sponsor
Fudan University
Target Recruit Count
102
Registration Number
NCT04608240
Locations
🇨🇳

Department of Anesthesiology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, Shanghai, China

Anti-PD-1 Antibody in the Treatment of Patients With Malignant Melanoma of the Female Genital Tract

Phase 2
Conditions
Malignant Melanoma
Interventions
First Posted Date
2020-10-20
Last Posted Date
2020-12-23
Lead Sponsor
Fudan University
Target Recruit Count
40
Registration Number
NCT04593485
Locations
🇨🇳

Fudan University Shanghai Cancer Center, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath